Immunomic Therapeutics, Inc.

ROCKVILLE, MD · Biotech · Private

Nanoplasmid DNA-based immunotherapy encoding allergens as LAMP chimeras for peanut allergy desensitization

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · immunomix.com

Sector: Biotech
Headquarters: ROCKVILLE, MD
Latest Form D: $6.5M, Jun 2025
Total capital: $30.9M

Federal grants: $495K; 3 awards · 2015–2016; Rank in peer group#273 of 502
Private capital raised: $30.4M; 9 Form D · last Jun 2025; 17 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 7; 33 pending · first 2017; Rank in peer group#11 of 502

Capital timeline

Latest events

Jun 2025Private capital raisedForm D · SEC · 9th filing$6.5M
Apr 2024Private capital raisedForm D · SEC · 8th filing$3M
Feb 2020Private capital raisedForm D · SEC · 7th filing$10M
Aug 2018Private capital raisedForm D · SEC · 6th filing$315K
Mar 2017Private capital raisedForm D · SEC · 5th filing$4.6M
Feb 2016Federal grantHealth and Human S · Phase I · Development of Nanoplasmid LAMP-based Peanut Allergy Immunotherapy$108K
Aug 2015Federal grantHealth and Human S · Phase I · TN-LAMP-vax: a Multi-Valent Tree Nut Allergy Immunotherapy$79K
Apr 2014Private capital raisedForm D · SEC · 4th filing$1M
Jun 2013Private capital raisedForm D · SEC · 3rd filing$2.7M
Jun 2013Private capital raisedForm D · SEC · 2nd filing$1.1M
Mar 2012Private capital raisedForm D · SEC · 1st filing$1.1M

Show 1 earlier federal award

Apr 2015Federal grantHealth and Human S · Phase I · Development of Nanoplasmid LAMP-based Peanut Allergy Immunotherapy$308K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 502 peers

Line = median

Biotech · Molecule

Federal grantsBelow median
Granted patents#11 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Teri Jones HeilandResearcherExecutive OfficerLinked by 5 patents
ALEX S KIMDirectorNamed in SEC Form D filings
ARLO P. MCGINNDirectorNamed in SEC Form D filings
Bernard C RudnickExecutive OfficerNamed in SEC Form D filings
Bruce C MacklerExecutive Officer, DirectorNamed in SEC Form D filings
C. ERIC WINZERExecutive Officer, DirectorNamed in SEC Form D filings

Show all 21 people

Dong-Gun KimExecutive Officer, DirectorNamed in SEC Form D filings
HYUK JOO P. JEEDirectorNamed in SEC Form D filings
James D. WishartExecutive Officer, DirectorNamed in SEC Form D filings
Ki-Hong AhnDirectorNamed in SEC Form D filings
Lisa C SalleyExecutive OfficerNamed in SEC Form D filings
Matthew ChangDirectorNamed in SEC Form D filings
Michael D. LackDirectorNamed in SEC Form D filings
Robert AhlgrenDirectorNamed in SEC Form D filings
RONALD P. THIBOUTOTDirectorNamed in SEC Form D filings
Steve ERIC ParkDirectorNamed in SEC Form D filings
WILLIAM G. HEARLExecutive Officer, DirectorNamed in SEC Form D filings
William Barry McDonaldDirectorNamed in SEC Form D filings
Winston I LoweExecutive OfficerNamed in SEC Form D filings
Yang Gon ERIC JinDirectorNamed in SEC Form D filings
YANG-GON P. JINDirectorNamed in SEC Form D filings

What it has protected

USPTO · 7 granted of 40

Jun 9, 2026GrantedImproved LAMP Constructs Comprising Cancer AntigensUSPTOUS 12,648,988
Nov 20, 2025PendingBicistronic LAMP Constructs Comprising Immune Response Enhancing Genes and Methods of Use ThereofUSPTOApplication 18854261
Oct 30, 2025PendingLamp Constructs Comprising Cancer AntigensUSPTOApplication 19230626

Show all 40 patent records

Improved LAMP Constructs Comprising Cancer AntigensJun 9, 2026 · US 12,648,988Granted
Bicistronic LAMP Constructs Comprising Immune Response Enhancing Genes and Methods of Use ThereofNov 20, 2025 · Application 18854261Pending
Lamp Constructs Comprising Cancer AntigensOct 30, 2025 · Application 19230626Pending
Lamp Constructs Comprising AllergensAug 26, 2025 · US 12,398,195Granted
Improved Lamp Constructs Comprising Cancer AntigensJul 15, 2025 · US 12,358,962Granted
LAMP ConstructsApr 3, 2025 · Application 18828394Pending
Anti-HVEM AntibodiesSep 26, 2024 · Application 18270036Pending
Nucleic Acids For Treatment Of AllergiesNov 28, 2023 · US 11,826,423Granted
Nucleic Acids for Treatment of AllergiesMar 17, 2022 · Application 17028762Pending
Improved Lamp ConstructsDec 21, 2021 · US 11,203,629Granted
Nucleic Acids for Treatment of Peanut AllergiesOct 3, 2019 · Application 16355785Pending
Nucleic Acids for Treatment of AllergiesSep 11, 2018 · US 10,072,053Granted
Nucleic Acids For Treatment Of Peanut AllergiesOct 26, 2017 · Application 15321366Pending
Nucleic Acids For Treatment Of AllergiesAug 29, 2017 · US 9,744,230Granted
Improved Lamp Constructs Comprising Cancer AntigensApplication PCTUS2018030725Pending
Improved Lamp ConstructsApplication PCTUS2018028753Pending
Zinc Finger Moiety Attached To A Resin Used To Purify Polynucleotide MoleculesApplication 62591444Pending
Nucleic Acids For Treatment Of AllergiesApplication PCTUS2017061847Pending
Lamp Constructs Comprising Cancer AntigensApplication 62561760Pending
Method Of Making AntibodiesApplication 62549033Pending
Lamp ConstructsApplication 62549119Pending
Nucleic Acids For Treatment Of Allergies In Veterinary UseApplication 62536088Pending
Lamp Constructs Comprising Cancer AntigensApplication 62500053Pending
Lamp ConstructsApplication 62488741Pending
Nucleic Acids For Treatment Of AllergiesApplication 62423111Pending
Nucleic Acids For Treatment Of Peanut AllergiesApplication PCTUS2015037240Pending
Nucleic Acids For Treatment Of AllergiesApplication PCTUS2012042552Pending
Anti-activin Receptor 1C (ALK-7) Receptor AntibodiesApplication 19607402Pending
Anti-activin Receptor 1C (ALK-7) Receptor AntibodiesApplication PCTUS2025012396Pending
Anti-activin Receptor 1C (ALK-7) Receptor AntibodiesApplication 63622658Pending
Bicistronic Lamp Constructs Comprising Immune Response Enhancing Genes And Methods Of Use ThereofApplication PCTUS2023065588Pending
Bicistronic LAMP Constructs Comprising Immune Response Enhancing Genes and Methods of Use ThereofApplication 63329463Pending
Anti-hvem AntibodiesApplication PCTUS2021065491Pending
Anti-hvem AntibodiesApplication 63131829Pending
Improved Lamp Constructs Comprising Cancer AntigensApplication PCTUS2020056197Pending
Improved Lamp Constructs Comprising Cancer AntigensApplication 62916854Pending
Improved Lamp Constructs Comprising AllergensApplication PCTUS2019032305Pending
Zinc Finger Moiety Attached To A Resin Used To Purify Polynucleotide MoleculesApplication PCTUS2018062861Pending
Lamp Constructs Comprising AllergensApplication 62673932Pending
Lamp Constructs Comprising AllergensApplication 62672378Pending

STATEGICS, INC.Similar federal contract value in Biotech · null in contracts
DFH Pharma, IncSimilar federal contract value in Biotech · null in contracts
TAMBO, INC.Similar federal contract value in Biotech · null in contracts
LYTICON, LLCSimilar federal contract value in Biotech · null in contracts
Bioprinting Laboratories Inc.Similar federal contract value in Biotech · null in contracts
HELIXOMER, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.